Plain-English translation of NCT06236789 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observation study—meaning researchers will look back at medical records of men who have already received a chemotherapy combination called for advanced prostate cancer that no longer responds to hormone therapy. The goal is to understand how effective this treatment was, what side effects patients experienced, and which patients benefited most from it.
Advanced prostate cancer that stops responding to hormone therapy is difficult to treat. This medication may help some patients, but doctors need real-world evidence from patient records to understand when and how well it works, and to identify which men are most likely to benefit.
You likely qualify if…
You likely don't qualify if…
You do not need to visit a clinic or take new medications for this study. Instead, researchers will review your existing medical records—including your cancer stage, treatment details, test results, and follow-up information—to analyze how you responded to the chemotherapy combination. The study team will collect this information from your medical providers and then use statistical methods to understand patterns in how the treatment worked for different patients.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
South Korea